Intramucosal bacteria in colon cancer and their elimination by probiotic strain Enterococcus faecium M-74 with organic selenium

. 2005 ; 50 (5) : 443-7.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid16475505

Intraepithelial bacteria were isolated by the gentamicin protection assay (GPA) from biopsy samples obtained at colonoscopy (colon cancer, n = 10 patients; colonic adenoma, n = 20; control group, n = 20; cancer patients without gastrointestinal tract GIT malignancy, n = 10). After a three-month administration of E. faecium M-74 to patients with positive GPA biopsies, 172 biopsy specimens from 60 patients were examined with the GPA. The number of biopsies with intracellular bacteria was significantly higher in adenoma and carcinoma group than in control group (26 vs. 10%; p = 0.004); in cancer patients without GIT malignancy the difference was nonsignificant. E. faecium M-74 was also administered to 5 patients with colonic adenoma; according to a control colonoscopy the number of biopsies with intracellular bacteria was significantly lower after probiotic administration (48 vs. 16%; p = 0.03). A striking prevalence of intraepithelial bacteria was also showed in patients with large bowel adenoma and carcinoma. The administration of probiotic strain M-74 can thus be considered to be an effective and promising method for elimination of pathogenic bacteria in the case of inflammatory bowel disease and colon cancer.

Zobrazit více v PubMed

World J Microbiol Biotechnol. 1995 May;11(3):294-8 PubMed

Folia Microbiol (Praha). 2004;49(3):301-5 PubMed

Bratisl Lek Listy. 1999 May;100(5):238-45 PubMed

Am J Clin Nutr. 2001 Feb;73(2 Suppl):451S-455S PubMed

Folia Microbiol (Praha). 2004;49(2):143-6 PubMed

Folia Microbiol (Praha). 2003;48(3):417-26 PubMed

Infect Immun. 2001 Sep;69(9):5529-37 PubMed

Aliment Pharmacol Ther. 2003 Jul 1;18(1):45-56 PubMed

Gastroenterology. 1998 Aug;115(2):281-6 PubMed

Gut. 2003 Jul;52(7):988-97 PubMed

Gastroenterology. 2004 Jul;127(1):80-93 PubMed

Folia Microbiol (Praha). 2002;47(5):573-8 PubMed

Gastroenterology. 2002 Jan;122(1):44-54 PubMed

J Antimicrob Chemother. 2001 May;47(5):709-10 PubMed

Gastroenterology. 2004 Aug;127(2):412-21 PubMed

Inflamm Bowel Dis. 2004 May;10(3):286-99 PubMed

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Inhibitory potential of lactobacilli against Escherichia coli internalization by HT 29 cells

. 2012 Jul ; 57 (4) : 269-72. [epub] 20120417

Probiotic potential of enterococci isolated from canine feed

. 2008 ; 53 (1) : 84-8. [epub] 20080515

Adaptation of adhesion test using Caco-2 cells for anaerobic bacterium Pseudobutyrivibrio xylanivorans, a probiotic candidate

. 2007 ; 52 (4) : 367-73.

Properties of the strains Enterococcus haemoperoxidus and E. moraviensis, new species among enterococci

. 2007 ; 52 (3) : 273-9.

Antimicrobial susceptibility of Enterococcus species isolated from Slovak Bryndza cheese

. 2007 ; 52 (2) : 115-9.

Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice

. 2006 ; 51 (5) : 478-84.

Probiotics manipulate host cytokine response and induce antimicrobial peptides

. 2006 ; 51 (5) : 507-10.

Effect of lactobacilli on E. coli adhesion to Caco-2 cells in vitro

. 2006 ; 51 (4) : 281-2.

Oral application of Enterococcus faecium strain EE3 in healthy dogs

. 2006 ; 51 (3) : 239-42.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...